USPTO amends patent term adjustment after Supernus
The US Patent and Trademark Office (USPTO) has amended its rules on patent term adjustment (PTA) to bring them in line with the US Court of Appeals for the Federal Circuit’s ruling in Supernus Pharma v Iancu in January this year.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
27 September 2021 The US Patent and Trademark Office has announced applicants can file for more prioritised examinations following an increase to the annual limit.